Itron (NASDAQ:ITRI) Issues Q1 2026 Earnings Guidance

Itron (NASDAQ:ITRI) updated its first quarter 2026 earnings guidance on Tuesday. The company provided EPS guidance of 1.200-1.300 for the period, compared to the consensus EPS estimate of 1.360. The company issued revenue guidance of $565.0 million-$575.0 million, compared to the consensus revenue estimate of $593.0 million. Itron also updated its FY 2026 guidance to 5.750-6.250 EPS.

Itron Price Performance

NASDAQ:ITRI traded up $7.07 during mid-day trading on Tuesday, reaching $96.43. 2,764,159 shares of the company were exchanged, compared to its average volume of 689,212. The company has a quick ratio of 1.91, a current ratio of 2.17 and a debt-to-equity ratio of 0.46. The stock has a market cap of $4.42 billion, a PE ratio of 17.34, a PEG ratio of 0.51 and a beta of 1.48. Itron has a 12 month low of $88.57 and a 12 month high of $142.00. The company has a fifty day moving average of $97.61 and a 200 day moving average of $110.66.

Itron (NASDAQ:ITRI) last announced its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.19 by $0.27. Itron had a net margin of 10.69% and a return on equity of 17.82%. The company had revenue of $571.66 million for the quarter, compared to analyst estimates of $561.31 million. During the same period in the prior year, the business earned $1.35 earnings per share. Itron’s quarterly revenue was down 6.7% on a year-over-year basis. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. On average, research analysts anticipate that Itron will post 5.33 EPS for the current fiscal year.

Wall Street Analyst Weigh In

ITRI has been the topic of a number of recent research reports. Weiss Ratings lowered Itron from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Robert W. Baird reiterated a “neutral” rating and issued a $118.00 price target (down previously from $137.00) on shares of Itron in a report on Friday, October 31st. Zacks Research cut Itron from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 28th. Oppenheimer cut their target price on shares of Itron from $145.00 to $125.00 and set an “outperform” rating on the stock in a research report on Tuesday, January 27th. Finally, Guggenheim set a $155.00 price target on shares of Itron in a research report on Friday. Seven analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Itron presently has a consensus rating of “Hold” and a consensus target price of $136.10.

Insider Activity at Itron

In other news, SVP Justin K. Patrick sold 379 shares of the company’s stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $96.51, for a total value of $36,577.29. Following the completion of the sale, the senior vice president directly owned 20,382 shares of the company’s stock, valued at $1,967,066.82. This represents a 1.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Christopher E. Ware sold 343 shares of the stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $96.51, for a total transaction of $33,102.93. Following the completion of the sale, the senior vice president owned 18,774 shares in the company, valued at $1,811,878.74. This represents a 1.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 3,113 shares of company stock worth $301,678. 1.51% of the stock is owned by company insiders.

Key Headlines Impacting Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Q4 beat and strong guidance — Itron reported non‑GAAP EPS of $2.46 (beat) and revenue above estimates; management gave Q1 2026 and full‑year 2026 revenue and non‑GAAP EPS ranges that imply growth and continued margin improvement, which is a primary driver of the stock move. Itron shares rise after Q4 profit surge, strong cash flow, and 2026 outlook
• Positive Sentiment: Margins and cash flow improved — GAAP gross margin expanded ~560 bps to ~40.5% and Q4 free cash flow was ~$112M (FY FCF ~$383M), signaling operating leverage that supports higher EPS and buyback/strategic investment optionality. Itron (ITRI) Reports Q4 Earnings: What Key Metrics Have to Say
• Positive Sentiment: Recurring revenue strategy and M&A — Itron closed the Locusview deal (and earlier Urbint) to accelerate software and recurring‑revenue mix; management commentary tied this strategy to future margin resilience and higher lifetime value. Backlog also stands at ~$4.5B. Itron Announces Fourth Quarter and Full Year 2025 Financial Results
• Neutral Sentiment: Full materials and commentary available — Earnings call transcript and slide deck provide details for modeling revenue mix, margin cadence, and FCF conversion; useful for investors refining estimates. Itron, Inc. (ITRI) Q4 2025 Earnings Call Transcript
• Negative Sentiment: Booking and regulatory headwinds noted — Some investor letters and coverage flagged softer-than-expected bookings and slower regulatory approvals in Q4, which could pressure near‑term revenue cadence despite margin gains. Softer Than Expected Booking Hurt Itron’s (ITRI) Shares in Q4
• Negative Sentiment: Insider selling — Recent disclosures show multiple insider sales over the last six months; heavy selling can be perceived negatively by some investors. Itron shares rise after Q4 profit surge, strong cash flow, and 2026 outlook

Institutional Trading of Itron

Several hedge funds have recently added to or reduced their stakes in the business. Employees Retirement System of Texas acquired a new position in Itron in the third quarter valued at about $32,000. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Itron by 29.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock valued at $41,000 after purchasing an additional 101 shares in the last quarter. Advisory Services Network LLC bought a new position in shares of Itron during the 3rd quarter valued at about $49,000. EverSource Wealth Advisors LLC grew its position in shares of Itron by 25.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after purchasing an additional 81 shares during the period. Finally, UMB Bank n.a. increased its stake in Itron by 271.6% during the 4th quarter. UMB Bank n.a. now owns 732 shares of the scientific and technical instruments company’s stock worth $68,000 after purchasing an additional 535 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.